Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study.
Madhavi EerikeVijaya Prasanna Pariminull D MAnand PyatiRaja SundaramurthySakthivadivel VaratharajanAswini Bramarambika Pidugunull Pharm DBhavana SurapareddyNaga Tejaswini RamineniRekha PriyadarshiniParag Parshuram PatilPublished in: Journal of rheumatic diseases (2023)
The study revealed that RA patients showed a reduced antibody response following COVID-19 vaccination compared to the control group and potentially influenced by immunosuppressive treatments and disease-related factors.
Keyphrases
- rheumatoid arthritis patients
- coronavirus disease
- disease activity
- sars cov
- rheumatoid arthritis
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- peritoneal dialysis
- systemic lupus erythematosus
- physical activity
- risk factors
- ankylosing spondylitis
- single cell
- drug induced